BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15840887)

  • 21. Case files of the New York City Poison Control Center: antidotal strategies for the management of methotrexate toxicity.
    Smith SW; Nelson LS
    J Med Toxicol; 2008 Jun; 4(2):132-40. PubMed ID: 18570175
    [No Abstract]   [Full Text] [Related]  

  • 22. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
    Counsel P; Khangure M
    Clin Radiol; 2007 Feb; 62(2):172-6. PubMed ID: 17207701
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of massive intrathecal methotrexate overdose by ventriculolumbar perfusion.
    Spiegel RJ; Cooper PR; Blum RH; Speyer JL; McBride D; Mangiardi J
    N Engl J Med; 1984 Aug; 311(6):386-8. PubMed ID: 6610829
    [No Abstract]   [Full Text] [Related]  

  • 24. Intrathecal methotrexate overdoses.
    Trinkle R; Wu JK
    Acta Paediatr; 1998 Jan; 87(1):116-7. PubMed ID: 9510464
    [No Abstract]   [Full Text] [Related]  

  • 25. Glucarpidase for the treatment of life-threatening methotrexate overdose.
    Tuffaha HW; Al Omar S
    Drugs Today (Barc); 2012 Nov; 48(11):705-11. PubMed ID: 23170306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Necrotizing myelopathy after intrathecal methotrexate].
    Sanhes L; Delmer A; Zittoun R
    Presse Med; 1997 May 3-10; 26(15):719. PubMed ID: 9183374
    [No Abstract]   [Full Text] [Related]  

  • 27. Transient encephalopathy following high-dose methotrexate.
    Lee AC; Li CH; Wong YC
    Med Pediatr Oncol; 2003 Jul; 41(1):101. PubMed ID: 12764767
    [No Abstract]   [Full Text] [Related]  

  • 28. Accidental overdose of intrathecal cytarabine in children.
    Thienprayoon R; Heym KM; Pelfrey L; Bowers DC
    Ann Pharmacother; 2013 May; 47(5):e24. PubMed ID: 23606548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Commentary.
    Milone MC
    Clin Chem; 2010 Dec; 56(12):1795-6. PubMed ID: 21119036
    [No Abstract]   [Full Text] [Related]  

  • 30. Not again! Erroneous intrathecal injection results from a problem with protocols.
    Seale JR
    BMJ; 2001 Mar; 322(7285):548. PubMed ID: 11230084
    [No Abstract]   [Full Text] [Related]  

  • 31. Commentary.
    Fox E; Balis FM
    Clin Chem; 2010 Dec; 56(12):1795. PubMed ID: 21119037
    [No Abstract]   [Full Text] [Related]  

  • 32. [Acute toxicity of high doses of methotrexate in treatment of ALL in children: a case study].
    Periáñez-Párraga L; Pérez-Rodríguez O; do Pazo-Oubiña F; Crespí-Monjo M
    Farm Hosp; 2009; 33(3):172-3. PubMed ID: 19712601
    [No Abstract]   [Full Text] [Related]  

  • 33. Hispanic ethnicity as a risk factor for requiring glucarpidase rescue in pediatric patients receiving high-dose methotrexate.
    Schafer ES; Bernhardt MB; Reichert KE; Haworth TE; Shah MD
    Am J Hematol; 2018 Feb; 93(2):E40-E42. PubMed ID: 29119597
    [No Abstract]   [Full Text] [Related]  

  • 34. Rescue of experimental intrathecal methotrexate overdose with carboxypeptidase-G2.
    Adamson PC; Balis FM; McCully CL; Godwin KS; Bacher JD; Walsh TJ; Poplack DG
    J Clin Oncol; 1991 Apr; 9(4):670-4. PubMed ID: 2066764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Carboxypeptidase-G2 rescue of methotrexate intoxication].
    Grill J; Amigo-Ferreiro ME; Schoepfer C; Bonnay M; Valteau-Couanet D; Hartmann O; Vassal G
    Bull Cancer; 1998 Dec; 85(12):1066. PubMed ID: 9917559
    [No Abstract]   [Full Text] [Related]  

  • 36. Delayed Methotrexate Clearance Despite Carboxypeptidase-G2 (Glucarpidase) Administration in 2 Patients With Toxic Methotrexate Levels.
    Wyatt KD; Cooper J; Scott K; Broomall E; Altaf S; Hogan MC; Rodriguez V; Khan S
    J Pediatr Hematol Oncol; 2018 Mar; 40(2):152-155. PubMed ID: 29240024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful large-volume cerebrospinal fluid aspiration for an accidental overdose of intrathecal cytarabine.
    Makar G; Al-Zubaidi M; Amar S; Feiz-Erfan I; Mehta D
    Med Oncol; 2013 Jun; 30(2):525. PubMed ID: 23463468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difficulty measuring methotrexate in a patient with high-dose methotrexate-induced nephrotoxicity.
    Al-Turkmani MR; Law T; Narla A; Kellogg MD
    Clin Chem; 2010 Dec; 56(12):1792-4. PubMed ID: 21119035
    [No Abstract]   [Full Text] [Related]  

  • 39. Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
    Goldstein DA; Tessler HH
    Am J Ophthalmol; 2007 Dec; 144(6):976; author reply 976. PubMed ID: 18036877
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute ascending motoric paraplegia following intrathecal chemotherapy for treatment of acute lymphoblastic leukemia in children: case reports and review of the literature.
    Rolf N; Boehm H; Kaindl AM; Lauterbach I; Suttorp M
    Klin Padiatr; 2006; 218(6):350-4. PubMed ID: 17080338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.